Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/21/2021
NMPA Issues Announcement for Applicability of ICH Guidelines Q3C (R8)
12/21/2021
CStone announced New Drug Approval of Cejemly® (Sugemalimab) in China
12/21/2021
CFDI Issues Five New Registration Verification and Inspection Related ...
12/21/2021
Ping An Good Doctor and Chugai Pharma China Enter Strategic Partnershi...
12/21/2021
Toray and 3SBio File Chinese NDA for Orally Disintegrating Antiprurit...
12/21/2021
Pfizer Wins Chinese BLA Approval of Inotuzumab Ozogamicin for BCP-ALL
12/21/2021
As U.S. Takes Aim at China Drug Makers, Innovators Appear at Biggest R...
12/21/2021
Alibaba and JD.Com's Healthcare Units Prepare for Next Battle in Criti...
12/20/2021
China's First Drug Patent Linkage Case Highlights Loophole, Lawyer War...
12/20/2021
NHSA Issues the List of DRG/DIP Reform Demo Trial Sites
12/20/2021
NHC Issues the Guidelines for Building and Management of Pharmacy Intr...
12/20/2021
CDE Publicizes the List of Reference Formulations for GQCE Studies (53...
12/20/2021
CDE Issues the Technical Guidance on Clinical Pharmacology Research of...
12/20/2021
CDE Issues the Rules for Principles and Procedures of Drug Registratio...
12/20/2021
Novartis and BeiGene Expands Collaboration to BeiGene's TIGIT Inhibito...
12/20/2021
AI-Powered Drug Discovery Firm 20n Bio Raises $3.3M in Seed Funding
12/20/2021
MOF: China To Lower Import Tariffs on 954 Products in 2022
12/20/2021
Novartis Granted Chinese Approval of Its Anti-CD20 Antibody Ofatumumab...
12/20/2021
Xpovio Combo Conditionally Approved in China for Repeatedly Treated rr...
12/20/2021
Cytokinetics and Ji Xing Expand Collaboration for Omecamtiv Mecarbil i...
12/17/2021
CBMG Cleared of U.S. IND of Bi-Specific CAR-T Cell Therapy C-CAR039...
12/17/2021
BioMarin and Skyline Therapeutics in Deal to Co-develop Novel Gene The...
12/17/2021
IQVIA: Chinese Retail Pharmacy Sales Up Only 0.3% in Q3/2021
12/17/2021
Review of Retail Pharmacy Sales of VBP Prevailing and Failure Drug Pro...
12/17/2021
The IPO Plans of 16 Chinese Medpharm Startups Failed to Win SSE STAR A...
12/17/2021
Data Snapshot – The Landscape of Innovative Biologics in China
12/17/2021
Recent Executive Moves
12/16/2021
US Sanctions Chinese Painkiller Makers Amid Addiction Epidemic, As Sen...
12/16/2021
Zai Lab's NUZYRA Approved in China as a Class 1 New Drug for CABP and ...
12/16/2021
US Sanctions Chinese Tech Firms/Institutes for Weaponizing Biotech, Sp...
Page:
100
/
719
Total number of articles:
21546
:
[First]
[<<]
[98]
[99]
[100]
[101]
[102]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit